Skip to main content

Table 3 Patients outcome

From: Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study

 

New-onset AF, no septic shock

(n = 26)

New-onset AF and septic shock

(n = 23)

Maintained SR and septic shock

(n = 27)

P1-value

P2-value

ICU-mortality

4 (15%)

10 (44%)

6 (22%)

0.06

0.14

28-day mortality

4 (15%)

9 (39%)

6 (22%)

0.10

0.22

60-day mortality

6 (23%)

11 (48%)

7 (26%)

0.08

0.14

ICU length of stay, days

(surviving patients)

10.5 (2-45)

(n = 22)

30 (9-123)

(n = 13)

17 (4-48)

(n = 21)

< 0.001

0.017

  1. Data are given as number (percentage) or median (range in parenthesis). P1-value, patients with new-onset AF without septic shock versus septic shock patients with new-onset atrial fibrillation (AF); P2-value, septic shock patients with new-onset AF versus septic shock patients with maintained sinus rhythm (SR).